Merck Serono
Royalty Monetization$55 Million
Nov 2008
MarketerMerck Serono
Cetrotide® is a fertility drug commonly used in in-vitro fertilization procedures. The gonadotropin releasing hormone (GnRH) antagonist is used to prevent premature ovulation in controlled ovarian stimulation prior to assisted reproductive technologies (ART).